PHILADELPHIA (October 14, 2022)—Therapy Choice, a Medicare Part B provider that specializes in in-home physical and occupational therapy, has enhanced its personalized home modification program through new partnerships with leading managed care organizations (MCOs). Over the past 20 years, Therapy Choice has been a provider for the Veterans Administration providing veterans with home modification recommendations in Pennsylvania and New Jersey, and now adds MCOs to its resume.

HOUSTON (December 14, 2021)—In the first extradition from the Republic of Cameroon to the United States, a Texas man was extradited to Houston on Friday to serve an 80-year prison sentence he received in absentia four years ago after he pleaded guilty in two separate cases to conspiracy, health care fraud, money laundering and tax offenses.

SAN DIEGO (October 22, 2019) ResMed introduced AirFit N30, a tube-down nasal cradle CPAP mask with a front-facing tub—a new option for sleep apnea treatment.

ResMed’s lightest mask yet, AirFit N30 features an adjustable elastic headgear, plus a nasal cradle cushion that sits under the nasal bridge, eliminating soreness in that area. The mask’s curved cushion is designed to provide a secure seal regardless of how the wearer sleeps or moves.

GREEN BAY, Wis. (August 28, 2018)—CorLife LLC, a provider of ancillary benefits and home modification services for workers’ compensation carriers nationwide, recently added a new company to their family of brands. CorCare is a home health care company that provides a wide variety of skilled services including all levels of nursing, occupational therapy, physical therapy, speech therapy, wound care, rehabilitation, translation, transportation and more.

Self-monitoring for CPAP patients increased adherence, ResMed study finds.

SAN DIEGO (November 21, 2017)—CHEST, the publication of the American College of Chest Physicians, has published a ResMed study that shows patient engagement apps significantly improve adherence to positive airway pressure (PAP) therapy.

The research included more than 128,000 patients, making it the world's largest study to look at sleep apnea and self-monitoring.